Manulife Hong Kong and Macau has appointed Mr Wilton Kee as CEO, effective 1 July 2026 and subject to regulatory approval.
Mr Kee joined Manulife in 2013 and has held a number of senior leadership roles across pricing, product, health and finance in Hong Kong SAR and Macau SAR. He previously served as Chief Product Officer and later assumed the additional role of Head of Health.
In 2022, he was appointed CFO, and in March 2026, took on additional responsibilities as Deputy CEO.
He will succeed Mr Patrick Graham.